cadenas
  • Innovative Therapies
    for Children with Cancer in Europe
  • Contact us

ITCC-061 EZH-102

A Phase 1 Study of EPZ-6438 (an EZH2 Inhibitor) in Pediatric Patients with Relapsed/Refractory INI1-Negative Tumors or Synovial Sarcomas

Promotor Name : EPIZYME

Investigator Name : F. BOURDEAUT

Trial registered on clinicaltrial.gov: NCT02601937